SEC 13F Intelligence

Hood River Capital Management LLC / ITCIEUR

Hood River Capital Management LLC’s Intra-Cellular Therapies Inc Position

Does Hood River Capital Management LLC own Intra-Cellular Therapies Inc (ITCIEUR)? Not currently — the last reported position was 615.2K shares worth $51M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$51M
Q4 2024
Shares
615.2K
% of Portfolio
+0.76%
Quarters Held
9
position exited

Position History ITCIEUR

Reported value by quarter
Q1 ’22: $31MQ1 ’22Q2 ’22: $36MQ3 ’22: $30MQ3 ’22Q4 ’22: $42MQ1 ’23: $45MQ1 ’23Q2 ’23: $53MQ2 ’24: $33MQ2 ’24Q3 ’24: $44MQ4 ’24: $51MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2024615.2K$51M+0.76%
Q3 2024600.0K$44M+0.71%
Q2 2024487.5K$33M+0.69%
Q2 2023839.1K$53M+1.58%
Q1 2023828.9K$45M+1.45%
Q4 2022793.7K$42M+1.53%
Q3 2022643.9K$30M+1.15%
Q2 2022632.0K$36M+1.43%
Q1 2022510.8K$31M+1.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hood River Capital Management LLC’s full portfolio or all institutional holders of ITCIEUR.